Novel carbamylated EPO and method for its production

Details for Australian Patent Application No. 2005259689 (hide)

Owner H. Lundbeck A/S

Inventors Munk, Morten; Thuesen, Marianne, Hallberg; Christensen, Soren; Pedersen, Anders, Hjelholt; Valbjorn, Jesper; Foldager, Lars

Agent Watermark

Pub. Number AU-B-2005259689

PCT Pub. Number WO2006/002646

Priority 60/586,370 07.07.04 US; PA 2004 01075 07.07.04 DK; 60/693,870 23.06.05 US

Filing date 7 July 2005

Wipo publication date 12 January 2006

Acceptance publication date 6 October 2011

International Classifications

C07K 14/505 (2006.01) Peptides having more than 20 amino acids

A61K 38/18 (2006.01) Medicinal preparations containing peptides - Growth factors

A61K 38/00 (2006.01) Medicinal preparations containing peptides

Event Publications

25 January 2007 PCT application entered the National Phase

  PCT publication WO2006/002646 Priority application(s): WO2006/002646

6 October 2011 Application Accepted

  Published as AU-B-2005259689

2 February 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005259699-A control device for a power supply with zero power consumption in standby mode

2005259686-Alpha-amylase variants with altered properties